ESLT Q4 2025 Earnings EPS Surges Past Expectations Amid Strong Defense Demand LEXX Q1 2026 Earnings Loss Narrower Than Expected Stock Jumps 73 HYNE Q1 2026 Earnings Mixed Operational Results Amid Net Loss ELTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline Host Hotels Resorts HST Q1 2026 Earnings A Stellar EPS Beat Fuels Market Optimism